Skip to content

Effect Of Ayurvedic Decoction in skin disease

A Controlled Phase II Clinical study to Evaluate the Efficacy of Trivrittadi kashaya as Virechan Kalpa in Dadru Kushtha with special reference to Tinea corporis - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/060060
Enrollment
60
Registered
2023-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 3: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Snehal Yashawnt Sarwate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with any of classical signs and symptoms of Dadru kushtha like Kandu(itching), Raga (redness), Pidika (papules/ elevation of skin), Mandala (rings). Patients of age group between 18 to 60 years of age are included. Patients of both sexes. Patients willing to participate in study and those who give written consent.

Exclusion criteria

Exclusion criteria: Patients below 18 years of age. Patients with other Skin Disorders like Eczema, Psoriasis. Pregnant women and lactating women. Virechan anarha rugna/ Patients not eligible for Virechan karma. Patients suffering from any chronic major illness. Patients suffering from auto-immune disorders like SLE.

Design outcomes

Secondary

MeasureTime frame
Symptomatic relief in kandu, mandala, raga, pidakaTimepoint: 15 Days

Primary

MeasureTime frame
Better symptomatic releif in Mandala, Kandu, raga, pidaka using Trivrittadi kashaya Timepoint: 15 Days

Countries

India

Contacts

Public ContactDr Savita Kulkarni

Ayurved Seva Sangh Arogyashala Rugnalaya, Nashik

drsavita.k07@gmail.com9423081487

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026